definiens: means ( i ) the Amine Neurotransmitter Reuptake - Inhibitor Compounds that are listed in Exhibit 1.1 G and those compounds that exist as of the Effective Date that ( a ) are owned solely or jointly by [COMPANY] or any of its Affiliates, ( b ) are known by [COMPANY] or any of its Affiliates to be Amine Neurotransmitter Reuptake - Inhibitor Compounds as of the Effective Date, and ( c ) [COMPANY] elects in writing to include them as [COMPANY] Compounds under this Agreement, ( ii ) all compounds first synthesized pursuant to the Research Program and owned solely or jointly by [COMPANY] or any of its Affiliates, ( iii ) all compounds Covered at the time of filing and/or at the time of grant by a compound claim of Patent Rights that are filed on any of the compounds included in item ( ii ), ( whether or not such 8 CONFIDENTIAL compounds in such claim are those of item ( ii » and such Patent Rights are owned solely or jointly by [COMPANY] or any of its AffIliates, and in each case such compounds are owned solely or jointly by [COMPANY] or any of its Affiliates, ( iv ) those compounds that ( a ) are Covered at the time of filing and/or at the time of grant by a compound claim of Patent Rights that are filed on any of the compounds included in item ( i ), ( whether or not such compounds in such claim are those of item ( i », and in each case such Patent Rights are owned solely by [COMPANY] or any of its Affiliates, and ( b ) [COMPANY] elects to include as [COMPANY] Compounds under this Agreement, ( v ) all isomers, enantiomers, hydrates, conjugates, esters, race mates, polymorphs . and metabolites of any of the foregoing compounds, ( vi ) all salt fonns of any of the foregoing compounds ; and ( vii ) all prodrugs of any of the foregoing compounds